HIGHLIGHTS
- who: Requestor European Commission and collaborators from the (UNIVERSITY) have published the Article: Statement on safety of cannabidiol as a novel food: data gaps and uncertainties, in the Journal: (JOURNAL) of 25/Nov/2015
- what: The clinical impact of this activity has not been assessed but, recently, a levothyroxine-CBD interaction was ceres Guido et_al, 2021) indicating a possible interaction of CBD with thyroid hormone reported (Ca concentrations via UGT.
- how: A similar observation was made with tacrolimus (Leino et_al 2019). The Panel notes that most human studies from the open literature concerning . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.